JPM vs NFBK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
NFBK presents a complex profile with a Piotroski F-Score of 4/9, indicating stable but mediocre financial health. While the trailing P/E of 692.50 is an extreme outlier, the Forward P/E of 9.23 and a Price-to-Book ratio of 0.84 suggest the market is pricing in a significant earnings recovery and valuing the company below its asset base. However, current profitability is critically low (ROE 0.11%) and the dividend payout ratio of 2600% is fundamentally unsustainable. The stock is currently trading at a massive premium to its Graham Number ($2.73) and Intrinsic Value ($0.14), indicating that the current price is driven by growth expectations rather than current fundamentals.
Compare Another Pair
Related Comparisons
JPM vs NFBK: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Northfield Bancorp, Inc. (NFBK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.